Natixis Advisors’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.9M Buy
37,403
+6,484
+21% +$1.85M 0.02% 624
2026
Q1
$5.36M Sell
30,919
-26,737
-46% -$5.48M 0.01% 822
2025
Q4
$14.8M Buy
57,656
+2,033
+4% +$533K 0.02% 569
2025
Q3
$14.5M Buy
55,623
+18,818
+51% +$4.95M 0.02% 573
2025
Q2
$9M Sell
36,805
-72,454
-66% -$18.1M 0.01% 679
2025
Q1
$28.9M Sell
109,259
-22,159
-17% -$5.99M 0.05% 337
2024
Q4
$33.3M Buy
131,418
+35,043
+36% +$9.4M 0.06% 300
2024
Q3
$30.5M Buy
96,375
+1,023
+1% +$364K 0.06% 310
2024
Q2
$35.6M Buy
95,352
+559
+0.6% +$189K 0.08% 252
2024
Q1
$32.9M Buy
94,793
+26,043
+38% +$9.87M 0.08% 269
2023
Q4
$31.5M Sell
68,750
-3,523
-5% -$1.74M 0.08% 255
2023
Q3
$35.2M Buy
72,273
+14,918
+26% +$7.01M 0.11% 211
2023
Q2
$25.6M Sell
57,355
-37,040
-39% -$18.6M 0.08% 256
2023
Q1
$45.8M Buy
94,395
+9,971
+12% +$4.93M 0.16% 151
2022
Q4
$43.2M Sell
84,424
-2,736
-3% -$1.44M 0.16% 160
2022
Q3
$42.3M Buy
87,160
+7,014
+9% +$3.41M 0.18% 146
2022
Q2
$37.5M Buy
80,146
+23,334
+41% +$10.4M 0.17% 152
2022
Q1
$24.7M Sell
56,812
-1,950
-3% -$816K 0.09% 239
2021
Q4
$27.3M Buy
58,762
+8,216
+16% +$3.64M 0.1% 218
2021
Q3
$19.7M Buy
50,546
+7,130
+16% +$3.03M 0.08% 254
2021
Q2
$19.2M Buy
43,416
+2,681
+7% +$1.17M 0.09% 259
2021
Q1
$17.1M Buy
40,735
+2,233
+6% +$891K 0.09% 258
2020
Q4
$15.8M Buy
38,502
+13,199
+52% +$5.49M 0.09% 252
2020
Q3
$10.5M Buy
25,303
+356
+1% +$143K 0.07% 315
2020
Q2
$9.67M Buy
24,947
+593
+2% +$222K 0.06% 323
2020
Q1
$7.65M Sell
24,354
-11,849
-33% -$4M 0.06% 330
2019
Q4
$13.3M Buy
36,203
+1,797
+5% +$570K 0.09% 253
2019
Q3
$8.8M Buy
34,406
+6,685
+24% +$1.87M 0.07% 311
2019
Q2
$7.35M Buy
27,721
+3,077
+12% +$780K 0.06% 348
2019
Q1
$6.55M Buy
24,644
+2,985
+14% +$860K 0.06% 361
2018
Q4
$6.2M Buy
21,659
+2,364
+12% +$749K 0.06% 340
2018
Q3
$6.53M Sell
19,295
-126
-0.6% -$40.9K 0.06% 376
2018
Q2
$5.78M Sell
19,421
-1,119
-5% -$328K 0.06% 405
2018
Q1
$5.52M Buy
20,540
+9,615
+88% +$2.6M 0.05% 404
2017
Q4
$2.71M Buy
10,925
+374
+4% +$92.4K 0.03% 614
2017
Q3
$2.57M Buy
+10,551
New +$2.59M 0.03% 657
2014
Q3
Sell
-4,519
Closed -$577K 1102
2014
Q2
$577K Buy
4,519
+508
+13% +$60.2K 0.01% 972
2014
Q1
$452K Buy
4,011
+707
+21% +$73.6K 0.01% 968
2013
Q4
$341K Buy
3,304
+228
+7% +$22.3K 0.01% 986
2013
Q3
$287K Sell
3,076
-1,431
-32% -$131K 0.01% 987
2013
Q2
$380K Buy
+4,507
New +$356K 0.01% 874

Other funds holding HUM

Natixis Advisors's HUM Position: Q2 2026 in Review

Natixis Advisors increased its Humana (HUM) stake by 21% in Q2 2026, buying an estimated $1.85M and bringing the position to 37,403 shares worth $14.9M. The position accounts for 0.02% of the portfolio, ranked #624.

Natixis Advisors first reported a position in HUM in Q2 2013 and has held it in 41 quarters since. The position peaked at $45.8M in Q1 2023. 923 funds tracked by Wall St. Rank hold HUM as of Q2 2026.

  • Natixis Advisors held 37,403 shares of Humana worth $14.9M as of Q2 2026.
  • Natixis Advisors bought 6,484 Humana shares in Q2 2026, an estimated $1.85M.
  • Humana made up 0.02% of Natixis Advisors's portfolio in Q2 2026, its #624 holding.
  • Natixis Advisors first reported a position in Humana in Q2 2013 and has held it in 41 quarters since.
  • Natixis Advisors's Humana position peaked at $45.8M in Q1 2023.
  • 923 funds tracked by Wall St. Rank held Humana as of Q2 2026.

Based on Natixis Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.